Overall, five-year survival rates for<unk>  are around 78% but may be affected by individual factors including<unk>  stage,<unk>  type, patient age and general medical health. Five-year survival is greater than 90% for patients with stage I lesions but decreases to 20% when pelvic lymph nodes are involved. Lymph node involvement is the most important predictor of prognosis. Prognosis depends on the stage of<unk> , which refers the amount and spread of<unk>  in the body. The stages are broken into four categories. Stage one also called "localized" and is when the<unk>  is limited to one part of the body. This has the highest survival rate of 59%. When the<unk>  starts to spread this is referred to "distant" or "regional", this stage usually involves the<unk>  being spread to the lymph nodes. This survival rate is 29%. The third stage is when the<unk>  has metastasized and spread throughout the body, this is the lowest survival rate of 6%. When<unk>  is caught early that is when the survival rate is at its highest.
Vulvar cancer
Lichen sclerosus
Genital ulcer
Hyperplasia
Amurca
Bartholin's cyst
Anal cancer
Atrophic vaginitis